Company Comparison
Ginkgo Bioworks vs 10x Genomics
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Ginkgo Bioworks | 10x Genomics |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | — | — |
| Founded | 2008 | — |
| Status | Active | Active |
| Last Funding Stage | — | — |
| Total Funding | $290M | — |
| Valuation | $4.2B | — |
What They Build
Ginkgo Bioworks
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT, headed by Jason Kelly.
10x Genomics
10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics.
Key Investors
Sector Overlap
Both Ginkgo Bioworks and 10x Genomics operate in Biotech.
Browse all Biotech companies →